Molecular detection of intestinal protozoa and microsporidia in HIV/AIDS patients

Sehriban Yurekturk1, Tuba Damar Cakırca2, Esra Gurbuz3

  • 1Vocational School of Health Services Van, Van Yüzüncü Yıl University, Türkiye.

Abstract

Insights

HIV/AIDS patients have a significantly higher risk of intestinal parasitic infections, including Blastocystis, microsporidia, Cryptosporidium, and Giardia. Routine screening of stool samples is recommended for early detection and management.

Area of Science:

  • Medical Parasitology
  • Infectious Diseases
  • Immunology

Background:

  • Opportunistic intestinal parasites pose a significant health risk to individuals with human immunodeficiency virus (HIV) infection.
  • Commonly implicated pathogens include Cryptosporidium spp., Giardia intestinalis, Blastocystis, and microsporidia species.

Purpose of the Study:

  • To investigate the prevalence of Cryptosporidium spp., Giardia intestinalis, Blastocystis, and microsporidia in HIV-infected patients using molecular methods.
  • To identify risk factors associated with these parasitic infections in the HIV-positive population.

Main Methods:

  • A molecular approach utilizing conventional and nested polymerase chain reaction (PCR) was employed.
  • The study included 100 HIV-seropositive patients and 50 healthy controls, excluding participants on antiparasitic treatment.

Main Results:

  • Higher prevalence rates of Blastocystis (22%), microsporidia (17%), Cryptosporidium spp. (12%), and G. intestinalis (11%) were observed in HIV/AIDS patients compared to controls.
  • Statistically significant differences in the detection rates of all four parasites were found between the patient and control groups (p < 0.05).
  • Multiple parasitic infections occurred in 12% of HIV/AIDS patients, a condition not observed in the control group.

Conclusions:

  • HIV/AIDS patients are at an elevated risk for infections with G. intestinalis, Cryptosporidium spp., microsporidia, and Blastocystis.
  • The high incidence of multiple parasitic infections underscores the need for comprehensive diagnostic strategies.
  • Routine screening of stool samples from HIV/AIDS patients using broad-spectrum molecular methods is crucial for effective management.